Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Alpha Teknova, Inc. (TKNO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TKNO at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,613 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (7.8) and balance sheet strength (12.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 18.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Alpha Teknova, Inc. reports quarterly revenue of $12.2M, net income of $-3.2M, free cash flow of $-596.0K. Top institutional holders of TKNO by reported 13-F value include ROYCE & ASSOCIATES, VANGUARD CAPITAL MANAGEMENT, Roubaix Capital, based on the most recent SEC filings. TKNO trades on the Nasdaq exchange and files with the SEC under CIK 1850902. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TKNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alpha Teknova, Inc. directly from SEC EDGAR.
AI Quality Score
26.6/100
AI Rank
#2,613
Revenue
$12.2M
Net Income
$-3.2M
Free Cash Flow
$-596.0K
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $40.5M | $-17.3M | -41.9% |
| FY 2024 | 10-K | $37.7M | $-26.7M | -69.3% |
| FY 2023 | 10-K | $36.7M | $-36.8M | -96.9% |
| FY 2022 | 10-K | $41.4M | $-47.5M | -119.9% |
| FY 2021 | 10-K | $36.9M | $-9.8M | -32.6% |
| FY 2020 | 10-K | $31.3M | $3.6M | 14.9% |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| ROYCE & ASSOCIATES | 1,661,395 | $9.4M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT | 1,614,045 | $9.2M | 2026-06-30 |
| Roubaix Capital | 1,579,404 | $9.0M | 2026-06-30 |
| BlackRock | 879,786 | $5.0M | 2026-06-30 |
| UBS Group AG | 631,967 | $3.6M | 2026-06-30 |
| Conestoga Capital Advisors | 314,554 | $1.8M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT | 311,818 | $1.8M | 2026-06-30 |
| BANK OF AMERICA | 255,760 | $1.5M | 2026-06-30 |
| GOLDMAN SACHS GROUP | 172,017 | $977.1K | 2026-06-30 |
| STATE STREET | 164,885 | $936.5K | 2026-06-30 |
13F Pro Quality Score
Rank #2,613 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk